Fusions involving known oncogenes often retain functional domains and are "in-frame," supporting their role in cancer, as noted in the Nature Communications study .
9,624 tumor samples from TCGA, investigating degron loss (a mechanism that stabilizes proteins, encouraging cancer growth). Key Findings: 24336.rar
Specific recurrent fusions validated included BCR-ABL, CCDC6-RET, and PML-RARA. Based on the information available, the number 24,336
Based on the information available, the number 24,336 appears in scientific research regarding and oncogene fusion analysis from The Cancer Genome Atlas (TCGA). Summary Report: Genetic Fusions Analysis Total Data Points Analyzed: 24,336 fusion genes. This research suggests that degron loss is a
The study highlights how losing a degron (a protein degradation signal) stabilizes the resulting fusion protein.
This research suggests that degron loss is a general mechanism in tumorigenesis, similar to promoter swapping, as shown in the study's PDF document .
Genetic fusions favor tumorigenesis through degron loss in oncogenes